Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cognyte Integrates with Microsoft Azure to Enhance AI Data Analytics Solution
-
red violet Announces Appointment of Greg Strakosch to Board of Directors
-
Magnite’s CTV Supply Leadership Is Unmatched With 99% Market Coverage, Shows Latest Jounce Report
-
Decibel Bio launches with $12M in financing to advance epigenetic plant programming platform
-
LyondellBasell to address J.P. Morgan 2025 Industrials Conference
-
Aktia Bank Plc: Managers’ Transactions – Aleksi Lehtonen
-
Aktia Bank Plc: Managers’ Transactions – Anssi Huhta
-
Aktia Bank Plc: Managers’ Transactions – Kati Eriksson
-
Vaisala Corporation’s conveyance of treasury shares in accordance with share-based incentive plan
-
Meriaura Group Oyj: Change of date for Meriaura Group Plc's Annual General Meeting 2025 – new members nominated for the Board of Directors following the merger of Meriaura Group Plc and Summa Defenc
-
Lassila & Tikanoja’s Annual Report 2024 has been published
-
Westlake Royal Building Products™ Expands Kleer® Cellular PVC Trim Lineup With New Reversible Nickel Gap/V-Groove Plank
-
Ripple News: BlocScale Launchpad on XRP Marks Explosive Growth, Set to Revolutionize Fundraising, and Embraces Real-World Asset Tokenization
-
National MS Society Launches "Tell MS It Ends With Us" Campaign During MS Awareness Week, March 9-15
-
JACKSON HEALTH FOUNDATION ANNOUNCES SECOND ANNUAL ONE DAY FOR JACKSON AND INTRODUCES ITS FIRST-EVER BENEFIT CONCERT ON APRIL 3
-
Acadia Healthcare Announces Launch of $500 Million Senior Notes Offering
-
Luhvee Books Announces Expansion of Personalized Handwritten Keepsakes, Defying AI Trends with Authentic, Meaningful Gifts
-
Sparked Host Launches FiveM Server Hosting
-
Dr. Rinku Ratti: Redefining Luxury Healthcare and Aesthetic Excellence at Birmingham’s Premier Private GP and Aesthetic Clinic
-
ZyVersa Therapeutics Highlights Data Demonstrating NLRP3 Inflammasome Inhibition Reduces Inflammation, Improves Heart Function, and Restores Glucose Homeostasis and Insulin Sensitivity in Obese Animal
-
Election of employee representatives to the Board of Directors
-
Terrestar Solutions and Monogoto Join Forces to Enable Seamless IoT Connectivity Across Canada with Hybrid Cellular-Satellite Technology
-
Allegiant Digital Joins Austin and Round Rock Chamber of Commerce
-
Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture
-
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
-
Forestar Group Inc. Announces Tender Offer for Any and All of its 3.850% Senior Notes due 2026
-
MEXC Lists RedStone (RED) with 300,000 USDT Prize Pool
-
Miami Beach Tanning Salon Introduces Airbrush Spray Tanning Service For A Natural Glow
-
Venu Holding Corporation Launches the VENU Income Fund
-
Stack Capital Group Inc. Invests $10 Million USD Into CoreWeave
-
Forestar Announces Proposed Offering of Senior Unsecured Notes
-
RAID: Shadow Legends Celebrates 6th Anniversary with Supreme Galek Giveaway for New Players
-
Fenix Outdoor completes acquisition of majority stake in Devold
-
Nebius accelerates US expansion, adding up to 300 MW capacity at new data center in New Jersey
-
Bread Financial Announces Approval of $150 Million Share Repurchase Program
-
Huawei Launches Four Innovative All-Optical Solutions to Build AI-Centric F5.5G All-Optical Networks for a Win-Win in the Intelligent Era
-
Share buy-back program
-
Boba Mint Announces Closing of Strategic Investment in Leading Blockchain/Crypto Gaming Company Werd Studios
-
Atlas Lithium Strengthens Position in Critical Minerals with Rare Earths, Titanium, Graphite, and Uranium Exposure
-
Groupon Announces Date for Fourth Quarter and Full Year 2024 Financial Results
-
Utilimaster Debuts Customer-Driven Work Truck Solutions to Enhance Service and Delivery Fleet Performance at NTEA Work Truck Week 2025
-
Bread Financial Announces Private Offering of Subordinated Notes
-
Compass Lexecon Adds Healthcare Economist Matthew Grennan
-
Abercrombie & Fitch Co. Reports Fourth Quarter and Full Year Results
-
SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT
-
Bowman Awarded Construction Oversight Contract by City of Wenatchee
-
Virax Biolabs to Present at 19th World Immune Regulation Meeting
-
Hercules Capital Announces Offering of $250.0 Million of Convertible Unsecured Notes
-
ICON plc to Present at Upcoming Investor Conferences
-
GD Culture Group Limited Announces Pricing of Private Placement
